Volume 9, Issue 3 pp. 295-299
Article
Full Access

Priapism complicating chronic granulocytic leukemia

R. Suri

R. Suri

The MRC Leukaemia Unit and Department of Haematology, Hammersmith Hospital and Royal Postgraduate Medical School, London W12 OHS

Search for more papers by this author
J. M. Goldman

Corresponding Author

J. M. Goldman

The MRC Leukaemia Unit and Department of Haematology, Hammersmith Hospital and Royal Postgraduate Medical School, London W12 OHS

MRC Leukaemia Unit, Royal Postgraduate Medical School, Ducane Road, London W12 OHS, EnglandSearch for more papers by this author
D. Catovsky

D. Catovsky

The MRC Leukaemia Unit and Department of Haematology, Hammersmith Hospital and Royal Postgraduate Medical School, London W12 OHS

Search for more papers by this author
S. A. Johnson

S. A. Johnson

The MRC Leukaemia Unit and Department of Haematology, Hammersmith Hospital and Royal Postgraduate Medical School, London W12 OHS

Search for more papers by this author
Eve Wiltshaw

Eve Wiltshaw

The Royal Marsden Hospital, Fulham Road, London SW7, England

Search for more papers by this author
D. A. G. Galton

D. A. G. Galton

The MRC Leukaemia Unit and Department of Haematology, Hammersmith Hospital and Royal Postgraduate Medical School, London W12 OHS

Search for more papers by this author
First published: November 1980
Citations: 23

Abstract

Since 1952 we have seen nine patients with priapism leading to a diagnosis of chronic granulocytic leukemia (CGL) and a tenth patient who gave a history of priapism when CGL was diagnosed as a result of other symptoms. Seven patients had had one or more transient episodes of prolonged erection before the diagnosis of CGL was established. All ten had high blood leukocyte counts (mean 380 × 109/liter, range 186-782) in comparison with other newly diagnosed patients. We estimate the incidence of this complication at 1%–2% of all male patients presenting with CGL. Treatment of patients in this series varied greatly. Five patients were treated mainly by local measures with or without cytotoxic drugs at conventional dosage, three were treated by sapheno-cavernous bypass operations and leukapheresis followed by cytotoxic drugs at high dosage, and two were treated initially by leukapheresis alone. In general, the prompt initiation of measures designed to reduce the leukocyte count seemed more valuable than the surgical procedures employed in these patients.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.